Target intelligence / Profile preview

Potassium channel subfamily K (K2P)

Target
K2P
Molecular classification
Ion channel, Potassium channel
01

Overview

Potassium channel subfamily K (K2P) members, also known as two-pore domain potassium channels, are a distinct family of ion channels responsible for leak or background potassium currents that stabilize the resting membrane potential (Enyedi & Czirják, 2010, Physiol Rev). Unlike other potassium channels, K2P channels possess four transmembrane segments and two pore-forming loops per subunit, typically functioning as dimers (Goldstein et al., 2005, Pharmacol Rev). They play a critical role in regulating the excitability of neurons, cardiomyocytes, and smooth muscle cells by responding to diverse physiological stimuli, including pH changes, mechanical stretch, temperature, and lipids (Feliciangeli et al., 2015, Pflugers Arch). Dysregulation of K2P channels is implicated in various pathologies, such as chronic pain, depression, cardiac arrhythmias, and pulmonary hypertension (Schmidt et al., 2012, Cardiovasc Res). Pharmacologically, these channels are notable targets for volatile anesthetics and are being explored for the development of novel analgesics and antidepressants (Bayliss & Barrett, 2008, Trends Pharmacol Sci). Their unique structure and gating mechanisms offer opportunities for selective modulation, although achieving high specificity remains a significant therapeutic challenge (Wulff et al., 2009, Nat Rev Drug Discov).

Other names
Two-pore domain potassium channelsKCNK channelsBackground potassium channels4-transmembrane-domain 2-pore-domain potassium channels
02

Mechanism of action

Drugs targeting K2P channels primarily act as either activators (openers) to hyperpolarize the cell membrane and reduce cellular excitability, or as inhibitors (blockers) to depolarize the membrane and increase excitability (Renigunta et al., 2015, Pflugers Arch).

03

Biological functions

Maintenance of resting membrane potentialRegulation of neuronal excitabilityPotassium homeostasisChemosensing (pH and oxygen)MechanosensingThermosensing
04

Disease associations

PainDepressionCardiac arrhythmiaPulmonary arterial hypertensionStrokeEpilepsyCancerInflammation
05

Safety considerations

Widespread expression leading to potential off-target effectsRisk of cardiac arrhythmiasPotential respiratory depressionDifficulty in achieving subtype-specific modulation
06

Interacting drugs

Isoflurane

8 more in the full profile.

07

Biomarkers

KCNK3 genetic variants (Pulmonary arterial hypertension)KCNK9 (TASK-3) overexpression (Breast and lung cancer)

Beyond the preview

Go deeper on Potassium channel subfamily K (K2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K (K2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call